Targeting nucleotide-requiring enzymes: Implications for diazoxide-induced cardioprotection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Dzeja, Petras P ^a   Bast, Peter ^a   Ozcan, Cevher ^a   Valverde, Arturo ^a   Holmuhamedov, Ekshon L ^a   Van Wylen, David G L ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

ATP sensitive potassium channel; Dehydrogenase; Mitochondria; Potassium channel openers

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATASE; DIAZOXIDE; FLAVINE ADENINE NUCLEOTIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGRADATION; DRUG EFFECT; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME REGULATION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; IC 50; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

EID: 0037377605     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00847.2002     Document Type: Article

References (73)

1. 1-ATP synthase by 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS). Z Naturforsch [C] 52: 799-806, 1997.
2. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79: 1127-1155, 1999.
3. ATP channel complex. FASEB J 14: 1943-1952, 2000.
4. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 105: 429-435, 1984.
5. ATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res 51: 691-700, 2001.
6. Czyz A, Szewczyk A, Nalecz MJ, and Wojtczak L. The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria. Biochem Biophys Res Commun 210: 98-104, 1995.
7. Demin OV, Gorianin II, Kholodenko BN, and Westerhoff HV. Kinetic modeling of energy metabolism and generation of active forms of oxygen in hepatocyte mitochondria. Mol Biol (Mosk) 35: 1095-1104, 2001.
8. 2·-generation in the complex III of the electron transport chain. Mol Cell Biochem 184: 21-33, 1998.
9. + channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284-H295, 2002.
10. Du G, Mouithys-Mickalad A, and Sluse FE. Generation of superoxide anion by mitochondria and impairment of their functions during anoxia and reoxygenation in vitro. Free Radic Biol Med 25: 1066-1074, 1998.
11. Dzeja PP, Holmuhamedov EL, Ozcan C, Pucar D, Jahangir A, and Terzic A. Mitochondria: gateway for cytoprotection. Circ Res 89: 744-746, 2001.
12. Dzeja PP, Toleikis AI, and Prashkiavichius AK. Effect of experimental myocardial infarction on the succinate oxidation rate and succinate dehydrogenase activity in heart mitochondria. Vopr Med Khim 26: 591-594, 1980.
13. + pump by D-glucose, glibenclamide or diazoxide. Int J Exp Diabetes Res 1: 265-274, 2001.
14. Eventoff W and Rossmann MG. The evolution of dehydrogenases and kinases. CRC Crit Rev Biochem 3: 111-140, 1975.
15. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
16. ATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 278: H305-H312, 2000.
17. Furuya A, Kashimoto S, and Kumazawa T. Effects of nicorandil on myocardial function and metabolism in the post-ischaemic reperfused heart with or without inhalation anaesthetics. Acta Anaesthesiol Scand 46: 24-29, 2002.
18. Grimmsmann T and Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br J Pharmacol 123: 781-788, 1998.
19. ATP channels in cardioprotection. Basic Res Cardiol 95: 280-284, 2000.
20. Grover GJ and Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32: 677-695, 2000.
21. Gutman M. Modulation of mitochondrial succinate dehydrogenase activity, mechanism and function. Mol Cell Biochem 20: 41-60, 1978.
22. Han J, Kim N, Park J, Seog DH, Joo H, and Kim E. Opening of mitochondrial ATP-sensitive potassium channels evokes oxygen radical generation in rabbit heart slices. J Biochem (Tokyo) 131: 721-727, 2002.
23. Hanley PJ, Mickel M, Loffler M, Brandt U, and Daut J. KATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 542: 735-741, 2002.
24. + channel openers prevent calcium overload in rat cardiac mitochondria. J Physiol 519: 347-360, 1999.
25. Jilkina O, Kuzio B, Grover GJ, and Kupriyanov W. Effects of KATP channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts. J Mol Cell Cardiol 34: 427-440, 2002.
26. Kissin I, Aultman DF, and Smith LR. Effects of volatile anesthetics on myocardial oxidation-reduction status assessed by NADH fluorometry. Anesthesiology 59: 447-452, 1983.
27. Kolocassides KG, Seymour AM, Galinanes M, Hearse DJ. Paradoxical effect of ischemic preconditioning on ischemic confracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol 28: 1045-1057, 1996.
28. Kopustinskiene D, Jovaisiene J, Liobikas J, and Toleikis A. Diazoxide and pinacidil uncouple pyruvate-malate-induced mitochondrial respiration. J Bioenerg Biomembr 34: 49-53, 2002.
29. Korge P, Honda HM, and Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA 99: 3312-3317, 2002.
30. Korshunov SS, Skulachev VP, and Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18, 1997.
31. + channel of heart mitochondria. Am J Physiol Heart Circ Physiol 280: H649-H657, 2001.
32. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, and Benoit JN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97: 365-373, 2002.
33. Lancaster CR. Succinate:quinone oxidoreductases: an overview. Biochim Biophys Acta 1553: 1-6, 2002.
34. ATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol 134: 535-542, 2001.
35. Liu Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998.
36. MacDonald MJ. The use of calcium uptake by small amounts of mitochondria from pancreatic islets to study mitochondrial respiration: the effects of diazoxide and sodium. Biochem Int 8: 771-778, 1984.
37. Mano T, Shinohara R, Nagasaka A, Nakagawa H, Uchimura K, Hayashi R, Nakano I, Tsugawa T, Watanabe F, Kobayashi T, Fujiwara K, Nakai A, and Itoh M. Scavenging effect of nicorandil on free radicals and lipid peroxide in streptozotocin-induced diabetic rats. Metabolism 49: 427-431, 2000.
38. + channels involves high-energy phosphate preservation. Am J Physiol Heart Circ Physiol 265: H1809-H1818, 1993.
39. Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, and Sack MN. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res 47: 68-73, 2000.
40. Mortimer SL, Kodl CT, Reiling CR, and Van Wylen DG. Preconditioning-induced attenuation of purine metabolite accumulation during ischemia: memory and multiple cycles. Basic Res Cardiol 95: 119-126, 2000.
41. Moreau C, Jacquet H, Prost AL, D'hahan N, and Vivaudou M. The molecular basis of the specificity of action of KATP channel openers. EMBO J 19: 6644-6651, 2000.
42. Murry CE, Richard VJ, Reimer KA, and Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931, 1990.
43. Narayan P, Mentzer RM Jr, and Lasley RD. Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 33: 121-129, 2001.
44. Ockaili R, Bhargava P, and Kukreja RC. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 280: H2406-H2411, 2001.
45. ATP channel change the function of mitochondria in situ? J Biol Chem 275: 37291-37295, 2000.
46. Ozcan C, Bienengraeber M, Dzeja PP, and Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 282: H531-H539, 2002.
47. Park JW, Chun YS, Kim YH, Kim CH, and Kim MS. Ischemic preconditioning reduces ROS generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci 60: 2207-2219, 1997.
48. Peralta C, Bulbena O, Xaus C, Prats N, Cutrin JC, Poli G, Gelpi E, and Rosello-Catafau J. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 73: 1203-1211, 2002.
49. Pieper GM and Gross GJ. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 6: 225-232, 1992.
50. Portenhauser R, Schafer G, and Trolp R. Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide. II. Interaction with energy conservation and ion transport. Biochem Pharmacol 20: 2623-2632, 1971.
51. 31P NMR. J Biol Chem 276: 44812-44819, 2001.
52. Rakhit RD, Mojet MH, Marber MS, and Duchen MR. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 103: 2617-2623, 2001.
53. Riepe MW and Ludolph AC. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem 174: 249-254, 1997.
54. Rouslin W. Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine 5′-triphosphatase in ischemic and autolyzing cardiac muscle. Possible mechanism for the mitigation of ATP hydrolysis under nonenergizing conditions. J Biol Chem 258: 9657-9661, 1983.
55. 2+-ATPase activity in rat heart homogenates. Anal Biochem 268: 79-88, 1999.
56. Sakai K, Akima M, Saito K, Saitoh M, and Matsubara S. Nicorandil metabolism in rat myocardial mitochondria. J Cardiovasc Pharmacol 35: 723-728, 2000.
57. Schafer G, Portenhauser R, and Trolp R. Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide. Action on succinate dehydrogenase and TCA-cycle oxidations. Biochem Pharmacol 20: 1271-1280, 1971.
58. Schafer G, Wegener C, Portenhauser R, and Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem Pharmacol 18: 2678-2681, 1969.
59. Skulachev VP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1363: 100-124, 1998.
60. Suleiman MS, Halestrap AP, and Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther 89: 29-46, 2001.
61. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109: 509-516, 2002.
62. Tamura JK, Rakov RD, and Cross RL. Affinity labeling of nucleotide-binding sites on kinases and dehydrogenases by pyridoxal 5′-diphospho-5′-adenosine. J Biol Chem 261: 4126-4133, 1986.
63. Terzic A, Dzeja PP, and Holmuhamedov EL. Mitochondrial KATP channels: probing molecular identity and pharmacology. J Mol Cell Cardiol 32: 1911-1915, 2000.
64. Toleikis A, Dzeja P, Praskevicius A, and Jasaitis A. Mitochondrial functions in ischemic myocardium. I. Proton electrochemical gradient, inner membrane permeability, calcium transport and oxidative phosphorylation in isolated mitochondria. J Mol Cell Cardiol 11: 57-76, 1979.
65. Vanden Hoek TL, Becker LB, Shao ZH, Li CQ, and Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541-548, 2000.
66. Vanden Hoek TL, Becker LB, Shao Z, Li C, and Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273: 18092-18098, 1998.
67. Vanden Hoek TL, Shao Z, Li C, Schumacker PT, and Becker LB. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol 29: 2441-2450, 1997.
68. Vincenti E, Branca D, Varotto ML, and Scutari G. Effects of halothane, enflurane and isoflurane on some energy-converting functions of isolated rat liver mitochondria. Agressologie 30: 517-520, 1989.
69. Wiegand F, Liao W, Busch C, Castell S, Knapp F, Lindauer U, Megow D, Meisel A, Redetzky A, Ruscher K, Trendelenburg G, Victorov I, Riepe M, Diener HC, and Dirnagl U. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 19: 1229-1237, 1999.
70. Wiesner RJ, Deussen A, Borst M, Schrader J, and Grieshaber MK. Glutamate degradation in the ischemic dog heart: contribution to anaerobic energy production. J Mol Cell Cardiol 21: 49-59, 1989.
71. Wohllk N, Thomas PM, Huang E, and Cote GJ. A human succinate-ubiquinone oxidoreductase CII-3 subunit gene ending in a polymorphic dinucleotide repeat is located within the sulfonylurea receptor (SUR) gene. Mol Genet Metab 65: 187-190, 1998.
72. ATP channel activity and cardiomyocyte protection. Anesthesiology 97: 15-23, 2002.
73. + conductance. Neuron 31: 233-245, 2001.